A study for evaluating the immunostimulating effect -A Randomized, double-blind, placebo controlled trial. - A study for evaluating the immunostimulating effect

ORTHOMEDICO, Inc.0 sites40 target enrollmentApril 19, 2016

Overview

No summary available.

Registry

who.int

Start Date

April 19, 2016

End Date

August 9, 2016

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

•a) Persons who have previous medical history of cancer, heart failure and cardiacinfarction b) Patients being treated for arterial fibrillation, cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes, digestive system disorder, autoimmune disorder, dyslipidemia, hypertension, and other chronic disease c) Persons who takes medicines, herbal medicines, and dietary supplements d) Persons who take in foods with an influence on Primary outcomes to more than three times a week in large quantities e) Persons who take in foods with an influence on intestinal regulation to more than three times a week in large quantities f) Persons who has allergy g) Pregnant women, lactating women, or women who want to get pregnant during the trial period h) Persons who enrolled in the other clinical trials within last 3 months before the agreement for the participation to the trial i) Persons who investigator judge not suitable to participate in the trial